Match tier Likely match
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-10

Sidney Veach Keisner

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Clinical Associate Professor

Also affiliated: RTX (United States) (2010); University of Arkansas Medical Center (2026); Central Arkansas Veterans Healthcare System (2015); VA North Texas Health Care System (2010–2011); Raytheon (United States) (2010); Texas Tech University Health Sciences Center (2010–2011)

4 h-index 13 pubs 166 cited

  • Humans
  • Male
  • Prostatic Neoplasms, Castration-Resistant
  • Bone Neoplasms
  • Middle Aged
  • Retrospective Studies
  • Bone Density Conservation Agents
  • Treatment Outcome
  • Aged
  • Aged, 80 and over
  • Drug Interactions
  • Animals
  • Carcinoma, Renal Cell
  • Indazoles
  • Kidney Neoplasms

Biography and Research Information

Metrics

  • h-index: 4
  • Publications: 13
  • Citations: 166

Positions

Selected Publications

  • Real-World Analysis of Adverse Events in Patients With Triple-Negative Breast Cancer Receiving Therapy per KEYNOTE-522 (2026)
    JCO Oncology Practice DOI OpenAlex
  • Abstract PS14-02: Real-world analysis comparing Black and White patients with triple-negative breast cancer receiving therapy per KEYNOTE-522 (2024)
    Cancer Research 3 citations DOI OpenAlex
  • Abstract PS14-06: Real-World Analysis of Adverse Events in Patients with Triple Negative Breast Cancer Receiving Therapy per KEYNOTE-522 (2024)
    Cancer Research 3 citations DOI OpenAlex
  • Prevention of Skeletal-Related Events With Extended-Interval Denosumab: A Review of the Literature (2023)
    Annals of Pharmacotherapy 4 citations DOI OpenAlex
  • Rucaparib and olaparib for the treatment of prostate cancer: A clinician's guide to choice of therapy (2022)
    Journal of Oncology Pharmacy Practice 13 citations DOI OpenAlex

View all publications on OpenAlex →